‘Science Speaks’ Highlights Study On Global Trends In CD4 Count At Start Of ART
IDSA’s “Science Speaks”: Study finds more than half of patients worldwide don’t access HIV treatment until immune systems are severely compromised
Antigone Barton, senior editor and writer of “Science Speaks,” discusses findings from a study published in Clinical Infectious Diseases on global trends in CD4 count at the start of antiretroviral therapy, writing, “Data from nearly a million patients starting treatment for HIV across the world over the last decade shows 55 percent of them accessed antiretroviral treatment only after their immune cell — or CD4 — counts had dropped below 200, leaving them extremely vulnerable to illnesses and infections” (2/1).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.